Stocks
Cortexyme () R&D US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 9.10 | 10.1 | 30.2 | 61.3 | 60.8 | 94.8 | |||
| Changes by years, y/y, % | +11% | +200% | +103% | -1% | +60.8% | ||||
Cortexyme. R&D, bln rub
Cortexyme. R&D, changes, %
Cortexyme. R&D, sum by quarters, bln rub
Cortexyme () R&D US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| R&D, bln rub | 14.7 | 14.0 | 60.8 | 12.8 | 7.20 | 94.8 | ||
| Changes by years, y/y, % | +4% | -17% | +283% | -24% | -51% | |||
| Changes by quarters, q/q, % | -13% | -5% | +333% | -79% | -44% | |||
